RGEN Q2 2025 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q2 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$182M+14.8% YoY

Gross Profit

$91M50.0% margin

Operating Income

$14M7.6% margin

Net Income

$15M8.2% margin

EPS (Diluted)

$0.26

QoQ Revenue Growth

+7.8%

Cash Flow

Operating Cash Flow

$29M

Free Cash Flow

$21M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$2.9B

Total Liabilities

$840M

Stockholders' Equity

$2.1B

Cash & Equivalents

$709M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$182M	$159M	+14.8%
Gross Profit	$91M	$73M	+24.3%
Operating Income	$14M	$7M	+86.7%
Net Income	$15M	$6M	+160.2%

Revenue Segments

Product

$182M100%

Royalty

$37,0000%